Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Unite disposes of nine properties, exits Aberdeen market

(Sharecast News) - Student accommodation provider Unite Group exchanged contracts for the disposal of a portfolio of nine properties on Thursday to an affiliate of Lone Star Funds. Unite said on Thursday that it will net £140.0m from the £212.0m sale of the assets in Aberdeen, Leicester, Leeds, Nottingham and Sheffield, with the disposals priced at a roughly 1% discount to their December 2024 book value and reflecting a net operating income yield of 6.4% based on 2025/26 income.

The FTSE 100-listed firm stated the disposal was part of its strategy to increase alignment with high and mid-ranked universities and properties, with the strongest prospects for sustainable long-term rental growth. It also highlighted that the disposal will see it fully exit the Aberdeen market.

Unite stated proceeds of the sale will be recycled into investment activity in the group's strongest markets, including its recently announced university partnership with Manchester Metropolitan University, and used to satisfy remaining redemption requests in USAF.

Chief executive Joe Lister said: "These disposals increase the alignment of our portfolio to the strongest university cities and continues our disciplined approach to recycling capital. Purpose-built student accommodation continues to attract institutional capital as the growing UK 18-year-old population and improving trends in international recruitment underpin demand for high-quality student accommodation".

As of 0730 BST, Unite shares were untraded at 854.54p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.